Feasibility study of key proposals to stimulate an increased number of company-initiated clinical trials in Sweden
The number of clinical trial applications submitted in Sweden has fallen sharply over the past decade. The consequences of a declining number of clinical trials include a reduced opportunity for Swedish patients to gain access to new innovative treatments. It is therefore of the utmost importance that Sweden succeeds in reversing the trend through various measures to enable better care for Swedish patients as well as to strengthen Swedish research.
Sirona Health Solutions, on behalf of Region Skåne, through their collaboration with the Research and Innovation Council of Skåne (FIRS) and SmiLe Incubator, has conducted a feasibility study to identify key factors that can stimulate an increased number of company-initiated clinical trials in Sweden.
"It is clear that efforts are needed at all levels to achieve a sustainable increase in the number of company-initiated clinical trials. The initiative from Region Skåne is an excellent example of how a region can tackle the problem where there is a mandate from politics, regional management and academia" - Shadi Abbas, Director at Sirona.
The report can be read in full here.
The feasibility study has been carried out within the Strategic Innovation Program Swelife, a joint initiative of Vinnova, Formas and the Swedish Energy Agency
